Investigational Drug Information for AZD1390
✉ Email this page to a colleague
What is the development status for investigational drug AZD1390?
AZD1390 is an investigational drug.
There have been 5 clinical trials for AZD1390.
The most recent clinical trial was a Phase 1 trial, which was initiated on April 2nd 2018.
The most common disease conditions in clinical trials are Neoplasms, Glioblastoma, and Carcinoma, Non-Small-Cell Lung. The leading clinical trial sponsors are AstraZeneca, University College London Hospitals, and University of Glasgow.
There are two US patents protecting this investigational drug and forty-seven international patents.
Summary for AZD1390
| US Patents | 2 |
| International Patents | 47 |
| US Patent Applications | 19 |
| WIPO Patent Applications | 4 |
| Japanese Patent Applications | 2 |
| Clinical Trial Progress | Phase 1 (2018-04-02) |
| Vendors | 40 |
Recent Clinical Trials for AZD1390
| Title | Sponsor | Phase |
|---|---|---|
| A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer | AstraZeneca | Phase 1 |
| A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Phase 0 Plus Expansion Study of AZD1390 in Recurrent GBM Patients | AstraZeneca | Early Phase 1 |
Clinical Trial Summary for AZD1390
Top disease conditions for AZD1390
Top clinical trial sponsors for AZD1390
US Patents for AZD1390
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| AZD1390 | ⤷ Try a Trial | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer | AstraZeneca AB (Sodertalje, SE) | ⤷ Try a Trial |
| AZD1390 | ⤷ Try a Trial | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer | AstraZeneca AB (Sodertalje, SE) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for AZD1390
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| AZD1390 | Argentina | AR106053 | 2035-09-17 | ⤷ Try a Trial |
| AZD1390 | Australia | AU2016323399 | 2035-09-17 | ⤷ Try a Trial |
| AZD1390 | Canada | CA2997399 | 2035-09-17 | ⤷ Try a Trial |
| AZD1390 | Chile | CL2018000677 | 2035-09-17 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
